| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Isoflurane | 20 | 2018 | 384 | 2.440 |
Why?
|
| Anesthesia, General | 13 | 2021 | 1174 | 2.140 |
Why?
|
| Anesthetics, Inhalation | 20 | 2018 | 572 | 1.940 |
Why?
|
| Nitrous Oxide | 7 | 2008 | 166 | 1.380 |
Why?
|
| Preoperative Care | 5 | 2020 | 2242 | 1.150 |
Why?
|
| Delirium | 12 | 2023 | 1667 | 1.110 |
Why?
|
| Cognition Disorders | 11 | 2017 | 3974 | 1.000 |
Why?
|
| Anesthesia | 9 | 2023 | 1591 | 0.900 |
Why?
|
| Maze Learning | 9 | 2020 | 481 | 0.740 |
Why?
|
| Postoperative Complications | 13 | 2023 | 15634 | 0.660 |
Why?
|
| Propofol | 4 | 2016 | 602 | 0.600 |
Why?
|
| Anesthetics | 3 | 2010 | 523 | 0.580 |
Why?
|
| Aging | 10 | 2018 | 8701 | 0.560 |
Why?
|
| Cognition | 9 | 2021 | 6987 | 0.550 |
Why?
|
| Anesthesiology | 4 | 2014 | 1121 | 0.510 |
Why?
|
| Hippocampus | 7 | 2018 | 3757 | 0.500 |
Why?
|
| Rats, Inbred F344 | 9 | 2008 | 826 | 0.490 |
Why?
|
| Neurosciences | 2 | 2019 | 369 | 0.480 |
Why?
|
| Neurotransmitter Agents | 1 | 2018 | 664 | 0.470 |
Why?
|
| Memory | 5 | 2012 | 2190 | 0.460 |
Why?
|
| Memory Disorders | 4 | 2008 | 1198 | 0.440 |
Why?
|
| Laparotomy | 1 | 2015 | 456 | 0.420 |
Why?
|
| Physician Executives | 1 | 2014 | 134 | 0.420 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 1409 | 0.420 |
Why?
|
| Anesthesia, Closed-Circuit | 1 | 2012 | 14 | 0.400 |
Why?
|
| Neural Stem Cells | 3 | 2018 | 886 | 0.400 |
Why?
|
| Central Nervous System | 1 | 2019 | 1333 | 0.390 |
Why?
|
| Entropy | 1 | 2012 | 210 | 0.370 |
Why?
|
| Nervous System | 2 | 2013 | 545 | 0.370 |
Why?
|
| Publishing | 1 | 2018 | 832 | 0.360 |
Why?
|
| Accreditation | 1 | 2014 | 473 | 0.350 |
Why?
|
| Social Environment | 1 | 2015 | 1021 | 0.350 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2005 | 894 | 0.340 |
Why?
|
| Specialties, Surgical | 1 | 2014 | 389 | 0.320 |
Why?
|
| Deep Sedation | 1 | 2010 | 118 | 0.310 |
Why?
|
| Rats | 17 | 2018 | 23713 | 0.310 |
Why?
|
| Dendritic Spines | 1 | 2010 | 242 | 0.300 |
Why?
|
| Neuropsychological Tests | 4 | 2021 | 7043 | 0.300 |
Why?
|
| Child Behavior | 1 | 2013 | 848 | 0.300 |
Why?
|
| Child Welfare | 1 | 2012 | 521 | 0.290 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2007 | 28 | 0.290 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 1276 | 0.290 |
Why?
|
| Parkinson Disease | 1 | 2021 | 2869 | 0.290 |
Why?
|
| Anesthesia, Inhalation | 1 | 2008 | 220 | 0.280 |
Why?
|
| Methyl Ethers | 3 | 2014 | 196 | 0.270 |
Why?
|
| Anesthetics, Intravenous | 2 | 2008 | 394 | 0.260 |
Why?
|
| Monitoring, Intraoperative | 2 | 2013 | 943 | 0.260 |
Why?
|
| Formaldehyde | 2 | 2004 | 357 | 0.250 |
Why?
|
| Conscious Sedation | 1 | 2010 | 533 | 0.250 |
Why?
|
| Age Factors | 9 | 2021 | 18385 | 0.240 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2004 | 57 | 0.240 |
Why?
|
| Genes, fos | 1 | 2004 | 175 | 0.230 |
Why?
|
| Dementia | 2 | 2016 | 2682 | 0.220 |
Why?
|
| Nicotinic Antagonists | 1 | 2003 | 94 | 0.220 |
Why?
|
| Piperidines | 1 | 2012 | 1656 | 0.210 |
Why?
|
| Spine | 2 | 2020 | 1128 | 0.210 |
Why?
|
| Pain Measurement | 2 | 2004 | 3548 | 0.210 |
Why?
|
| Brain Ischemia | 1 | 2016 | 3031 | 0.210 |
Why?
|
| Animals | 36 | 2023 | 168083 | 0.210 |
Why?
|
| Neurosurgery | 2 | 2013 | 679 | 0.200 |
Why?
|
| Psychomotor Performance | 4 | 2011 | 1881 | 0.200 |
Why?
|
| Endovascular Procedures | 1 | 2016 | 2181 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 7 | 2014 | 3840 | 0.200 |
Why?
|
| Nervous System Diseases | 2 | 2014 | 1663 | 0.200 |
Why?
|
| Child Development | 1 | 2013 | 2302 | 0.200 |
Why?
|
| Synapses | 2 | 2017 | 1755 | 0.190 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 1463 | 0.190 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2372 | 0.190 |
Why?
|
| Space Perception | 1 | 2004 | 465 | 0.190 |
Why?
|
| Caspase 3 | 5 | 2016 | 730 | 0.190 |
Why?
|
| Anesthesia, Spinal | 1 | 2004 | 279 | 0.190 |
Why?
|
| Stroke | 3 | 2016 | 9720 | 0.180 |
Why?
|
| Brain | 8 | 2020 | 27097 | 0.180 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 3627 | 0.180 |
Why?
|
| Alzheimer Disease | 6 | 2023 | 8601 | 0.180 |
Why?
|
| Receptors, Nicotinic | 1 | 2003 | 494 | 0.170 |
Why?
|
| Olfaction Disorders | 1 | 2022 | 224 | 0.170 |
Why?
|
| Interleukin-1beta | 2 | 2018 | 1002 | 0.160 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 457 | 0.160 |
Why?
|
| Behavior, Animal | 3 | 2020 | 1873 | 0.160 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2002 | 370 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2018 | 8164 | 0.150 |
Why?
|
| Longevity | 1 | 2006 | 1064 | 0.150 |
Why?
|
| Disease Models, Animal | 4 | 2015 | 18217 | 0.150 |
Why?
|
| Humans | 47 | 2023 | 761098 | 0.150 |
Why?
|
| Neurons | 5 | 2018 | 9435 | 0.140 |
Why?
|
| Environmental Exposure | 1 | 2012 | 4479 | 0.140 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 3707 | 0.130 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 602 | 0.130 |
Why?
|
| Spinal Cord | 1 | 2004 | 1807 | 0.130 |
Why?
|
| Surgical Procedures, Operative | 2 | 2020 | 1923 | 0.130 |
Why?
|
| Male | 27 | 2021 | 360675 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2018 | 4340 | 0.130 |
Why?
|
| Staurosporine | 2 | 2016 | 241 | 0.120 |
Why?
|
| Research | 1 | 2003 | 1975 | 0.120 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 15308 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2018 | 2518 | 0.110 |
Why?
|
| Oxytocin | 1 | 2018 | 402 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2014 | 5879 | 0.110 |
Why?
|
| Prenatal Injuries | 1 | 2013 | 13 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 10 | 2018 | 22129 | 0.110 |
Why?
|
| Neurogenesis | 2 | 2018 | 861 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1176 | 0.110 |
Why?
|
| Aged | 13 | 2023 | 169266 | 0.110 |
Why?
|
| Tight Junctions | 1 | 2015 | 324 | 0.100 |
Why?
|
| Apoptosis | 5 | 2016 | 9478 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 412 | 0.100 |
Why?
|
| Models, Animal | 1 | 2018 | 2114 | 0.100 |
Why?
|
| Interleukin-6 | 4 | 2022 | 3210 | 0.100 |
Why?
|
| Deoxyuridine | 1 | 2011 | 34 | 0.100 |
Why?
|
| Propidium | 1 | 2011 | 42 | 0.100 |
Why?
|
| Acute Lung Injury | 1 | 2015 | 367 | 0.100 |
Why?
|
| Enzyme Activation | 7 | 2014 | 3577 | 0.100 |
Why?
|
| Fellowships and Scholarships | 2 | 2013 | 1116 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 1702 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 5777 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2200 | 0.090 |
Why?
|
| Neurology | 1 | 2019 | 784 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 2725 | 0.090 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 262 | 0.090 |
Why?
|
| Efficiency | 1 | 2014 | 476 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10421 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 9416 | 0.090 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 411 | 0.090 |
Why?
|
| Random Allocation | 3 | 2013 | 2393 | 0.090 |
Why?
|
| Microglia | 1 | 2019 | 1357 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3419 | 0.090 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2011 | 286 | 0.080 |
Why?
|
| Mice | 14 | 2023 | 81324 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1589 | 0.080 |
Why?
|
| Female | 21 | 2021 | 392458 | 0.080 |
Why?
|
| Culture Media | 1 | 2011 | 894 | 0.080 |
Why?
|
| Neuroglia | 3 | 2018 | 954 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 11066 | 0.080 |
Why?
|
| Carcinogens | 1 | 2011 | 452 | 0.080 |
Why?
|
| Pain | 1 | 2004 | 5070 | 0.080 |
Why?
|
| Oxygen | 1 | 2021 | 4226 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2011 | 562 | 0.080 |
Why?
|
| Prospective Studies | 6 | 2022 | 54419 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 2067 | 0.080 |
Why?
|
| Caspases | 2 | 2008 | 878 | 0.080 |
Why?
|
| Length of Stay | 2 | 2020 | 6420 | 0.070 |
Why?
|
| Memantine | 1 | 2008 | 108 | 0.070 |
Why?
|
| Risk Factors | 6 | 2023 | 74219 | 0.070 |
Why?
|
| Inflammation | 2 | 2019 | 10758 | 0.070 |
Why?
|
| Nerve Net | 1 | 2019 | 2290 | 0.070 |
Why?
|
| Haplorhini | 1 | 2007 | 523 | 0.070 |
Why?
|
| Neurotoxins | 1 | 2008 | 240 | 0.070 |
Why?
|
| Child Behavior Disorders | 1 | 2011 | 804 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 10213 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7400 | 0.070 |
Why?
|
| Cell Death | 1 | 2011 | 1676 | 0.070 |
Why?
|
| Gene Expression | 1 | 2018 | 7567 | 0.060 |
Why?
|
| Patient Care | 1 | 2011 | 622 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 4 | 2014 | 619 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5249 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2019 | 8478 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2018 | 18926 | 0.060 |
Why?
|
| Cytosol | 1 | 2008 | 883 | 0.060 |
Why?
|
| Learning | 2 | 2012 | 1739 | 0.060 |
Why?
|
| Anesthetics, Combined | 1 | 2004 | 43 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2012 | 2764 | 0.060 |
Why?
|
| Ephedrine | 1 | 2004 | 52 | 0.060 |
Why?
|
| Respiratory Protective Devices | 1 | 2004 | 47 | 0.060 |
Why?
|
| Mitochondria | 2 | 2020 | 3620 | 0.060 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 2023 | 36 | 0.060 |
Why?
|
| Laryngeal Masks | 1 | 2004 | 102 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 747 | 0.050 |
Why?
|
| Boston | 1 | 2016 | 9324 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2757 | 0.050 |
Why?
|
| Nasal Septum | 1 | 2004 | 130 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2011 | 1510 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2007 | 697 | 0.050 |
Why?
|
| Nuclease Protection Assays | 1 | 2002 | 14 | 0.050 |
Why?
|
| Hypoxia, Brain | 1 | 2003 | 138 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1885 | 0.050 |
Why?
|
| Pregnancy | 5 | 2018 | 29872 | 0.050 |
Why?
|
| Hypercapnia | 1 | 2003 | 261 | 0.050 |
Why?
|
| Paranasal Sinuses | 1 | 2004 | 265 | 0.050 |
Why?
|
| Hip Fractures | 1 | 2010 | 989 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 1433 | 0.050 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2021 | 34 | 0.050 |
Why?
|
| Portugal | 1 | 2021 | 91 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 4405 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2014 | 3441 | 0.050 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2004 | 324 | 0.050 |
Why?
|
| Hospitals | 1 | 2014 | 3881 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2004 | 654 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1544 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 58946 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2023 | 696 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2021 | 24013 | 0.040 |
Why?
|
| Curriculum | 1 | 2013 | 3739 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4565 | 0.040 |
Why?
|
| Prevalence | 1 | 2016 | 15717 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2006 | 1242 | 0.040 |
Why?
|
| Time | 1 | 2020 | 545 | 0.040 |
Why?
|
| tau Proteins | 2 | 2023 | 2094 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 510 | 0.040 |
Why?
|
| Motivation | 1 | 2008 | 2003 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2023 | 8303 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 252 | 0.040 |
Why?
|
| Clioquinol | 2 | 2008 | 23 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3776 | 0.040 |
Why?
|
| Vitamin K 2 | 1 | 2017 | 47 | 0.040 |
Why?
|
| Synaptophysin | 1 | 2017 | 139 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 9518 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 2018 | 69 | 0.040 |
Why?
|
| Leadership | 1 | 2007 | 1386 | 0.040 |
Why?
|
| Hypotension | 1 | 2003 | 879 | 0.030 |
Why?
|
| Time Factors | 3 | 2016 | 39953 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2012 | 5033 | 0.030 |
Why?
|
| Cell Survival | 3 | 2016 | 5776 | 0.030 |
Why?
|
| Dentate Gyrus | 1 | 2017 | 165 | 0.030 |
Why?
|
| Catheterization | 1 | 2002 | 1428 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2004 | 1037 | 0.030 |
Why?
|
| Patient Selection | 1 | 2008 | 4245 | 0.030 |
Why?
|
| Probiotics | 1 | 2020 | 378 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2008 | 309 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2021 | 739 | 0.030 |
Why?
|
| General Surgery | 1 | 2007 | 1692 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 2017 | 366 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2020 | 765 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6224 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2004 | 2567 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 26068 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 730 | 0.030 |
Why?
|
| Calcium | 1 | 2008 | 5720 | 0.030 |
Why?
|
| Escape Reaction | 1 | 2014 | 57 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 9001 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2019 | 1818 | 0.030 |
Why?
|
| Cell Line, Tumor | 5 | 2009 | 16947 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 864 | 0.030 |
Why?
|
| Oligodendroglia | 1 | 2018 | 538 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3803 | 0.030 |
Why?
|
| Ibuprofen | 1 | 2014 | 229 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2011 | 1140 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 64670 | 0.020 |
Why?
|
| RNA | 1 | 2002 | 2708 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 436 | 0.020 |
Why?
|
| Oligopeptides | 2 | 2008 | 1178 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1780 | 0.020 |
Why?
|
| Lithium | 1 | 2014 | 596 | 0.020 |
Why?
|
| United States | 3 | 2011 | 72337 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 1987 | 0.020 |
Why?
|
| Reaction Time | 1 | 2017 | 2087 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4111 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2006 | 1111 | 0.020 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2012 | 158 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2018 | 2915 | 0.020 |
Why?
|
| Astrocytes | 1 | 2018 | 1341 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 26187 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3836 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1738 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2018 | 2547 | 0.020 |
Why?
|
| Placenta | 1 | 2018 | 1709 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 11856 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 1178 | 0.020 |
Why?
|
| Abdomen | 1 | 2014 | 1128 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 1157 | 0.020 |
Why?
|
| Phlebotomy | 1 | 2008 | 137 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 2666 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2008 | 230 | 0.020 |
Why?
|
| Ganglioglioma | 1 | 2007 | 36 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 427 | 0.020 |
Why?
|
| Denervation | 1 | 2008 | 265 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2007 | 188 | 0.020 |
Why?
|
| Carbamates | 1 | 2008 | 191 | 0.020 |
Why?
|
| Spinal Puncture | 1 | 2008 | 282 | 0.020 |
Why?
|
| Health Status | 1 | 2019 | 4077 | 0.020 |
Why?
|
| Dipeptides | 1 | 2008 | 387 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1967 | 0.020 |
Why?
|
| Cholinergic Antagonists | 1 | 2006 | 167 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 656 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2007 | 383 | 0.020 |
Why?
|
| Fear | 1 | 2014 | 1478 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2008 | 809 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 7386 | 0.010 |
Why?
|
| Plaque, Amyloid | 1 | 2009 | 761 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2006 | 629 | 0.010 |
Why?
|
| Incidence | 1 | 2023 | 21357 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1812 | 0.010 |
Why?
|
| Copper | 1 | 2007 | 365 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10755 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2138 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2019 | 6242 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 793 | 0.010 |
Why?
|
| Wound Healing | 1 | 2014 | 2801 | 0.010 |
Why?
|
| Zinc | 1 | 2007 | 672 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 2004 | 290 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2006 | 1756 | 0.010 |
Why?
|
| Serotonin | 1 | 2006 | 1043 | 0.010 |
Why?
|
| Radiography | 1 | 2013 | 6975 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5870 | 0.010 |
Why?
|
| Melatonin | 1 | 2006 | 668 | 0.010 |
Why?
|
| Middle Aged | 3 | 2023 | 220835 | 0.010 |
Why?
|
| Motor Activity | 1 | 2011 | 2712 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 80673 | 0.010 |
Why?
|
| Amino Acids | 1 | 2006 | 1703 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2006 | 2599 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11505 | 0.010 |
Why?
|
| Body Weight | 1 | 2011 | 4618 | 0.010 |
Why?
|
| Critical Care | 1 | 2013 | 2690 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 1967 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3700 | 0.010 |
Why?
|
| Health Surveys | 1 | 2008 | 4036 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 3725 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 2457 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15542 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41486 | 0.010 |
Why?
|
| Pediatrics | 1 | 2013 | 3589 | 0.010 |
Why?
|
| Anxiety | 1 | 2011 | 4572 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2004 | 1331 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 3197 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5103 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2008 | 3429 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9455 | 0.010 |
Why?
|
| Glioma | 1 | 2006 | 3452 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 9025 | 0.000 |
Why?
|
| Adult | 2 | 2013 | 221083 | 0.000 |
Why?
|
| Child | 1 | 2013 | 80134 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 36418 | 0.000 |
Why?
|